Efficacy and Safety of Tazbentetol in ALS Participants

Clinical trial NCT07325591 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07325591
Sponsor: Spinogenix
Status: NOT_YET_RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis

Start date: 2026-03-01
Primary completion: 2027-12-31
Enrollment: 430

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.